Robert Hugin is chairman and CEO of Celgene, a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and immune-inflammatory disease. He joined Celgene in June 1999 and has been a director of the company since December 2001. Hugin is past chairman of the board of the Pharmaceutical Research and Manufacturers of America and is a member of the board of trustees of Princeton University, the Medicines Co. and the Darden Foundation at the University of Virginia. He is also a member of the board of Atlantic Health System and of Family Promise, a national nonprofit network assisting homeless families. Before joining Celgene, Hugin was a managing director with JP Morgan & Co. Inc. He holds a B.A. from Princeton University and an M.B.A. from the University of Virginia.

Healthcare Business,